Evaluation of a New Treatment for Migraine Attacks

Karolinska University Hospital

Status: Completed

Conditions: Migraine

Treatments: Device: Migraine Medical Device; Device: Inactive Migraine Medical Device

Study type: Interventional

Funder types: Other

Identifiers

NCT01880671

Migraine2013/657-32

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of a novel therapy for treatment of migraine, pain reduction and relief of associated symptoms during ongoing migraine attacks, and presence of a preventive effect post treatment.

Enrollment: 36 patients

Sex: All

Ages: 20 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female or male subjects, in otherwise good health, 20 to 55 years of age
• Subjects who meet the ICHD-2 (2nd Edition of The International Headache Classification) criteria for migraine headache
• Subjects with a minimum of 1 migraine attack per month
• Attack duration of 4 to 72 hours
• Normal attack intensity of at least 4 on a 0-10 VAS-scale

Exclusion criteria

• Completed heart surgery
• Cardiovascular disease
• Vascular damage on neck vessels
• Disease other than migraine of the CSN
• Severe disease of vital body organs
• Severe psychiatric disorders
• More than 6 migraine attacks per month

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

36 participants in 2 patient groups, including a placebo group

Migraine Medical Device

Experimental group

Treatment:

Device: Migraine Medical Device

Inactive Migraine Medical Device

Placebo Comparator group

Treatment:

Device: Inactive Migraine Medical Device